Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-12 1:33 pm Unchanged | 13G | Actinium Pharmaceuticals Inc. ATNM | VANGUARD GROUP INC | 1,625,000 5.210% | 0 (Unchanged) | View |
| 2024-11-08 6:51 pm Sale | 13G | Actinium Pharmaceuticals Inc. ATNM | Bigger Capital LLC | 1,555,313 11.000% | -339,889 (-17.93%) | View |
| 2024-11-04 11:47 am Unchanged | 13G | Actinium Pharmaceuticals Inc. ATNM | VANGUARD GROUP INC | 1,625,000 5.210% | 0 (Unchanged) | View |
| 2024-11-04 11:10 am Purchase | 13G | Actinium Pharmaceuticals Inc. ATNM | VANGUARD GROUP INC | 1,625,000 5.210% | 1,625,000 (New Position) | View |
| 2024-02-09 4:30 pm Purchase | 13G | Actinium Pharmaceuticals Inc. ATNM | Bigger Capital LLC | 1,895,202 6.800% | 1,895,202 (New Position) | View |
| 2024-01-29 3:26 pm Purchase | 13G | Actinium Pharmaceuticals Inc. ATNM | BlackRock Inc. BLK | 1,691,914 6.200% | 1,691,914 (New Position) | View |
| 2023-02-06 4:28 pm Purchase | 13G | Actinium Pharmaceuticals Inc. ATNM | BIGGER CAPITAL FUND L P | 1,691,667 6.600% | 377,561 (+28.73%) | View |
| 2022-02-08 8:53 pm Purchase | 13G | Actinium Pharmaceuticals Inc. ATNM | BIGGER CAPITAL FUND L P | 1,314,106 6.000% | 380,478 (+40.75%) | View |
| 2021-02-12 4:30 pm Purchase | 13G | Actinium Pharmaceuticals Inc. ATNM | BIGGER CAPITAL FUND L P | 933,628 6.900% | 128,569 (+15.97%) | View |
| 2021-01-05 4:40 pm Purchase | 13G | Actinium Pharmaceuticals Inc. ATNM | SABBY MANAGEMENT LLC | 630,637 11.000% | 630,637 (New Position) | View |
| 2020-08-11 5:37 pm Purchase | 13G | Actinium Pharmaceuticals Inc. ATNM | BIGGER CAPITAL FUND L P | 805,059 5.900% | 805,059 (New Position) | View |
| 2020-05-01 08:38 am Purchase | 13G | Actinium Pharmaceuticals Inc. ATNM | SABBY MANAGEMENT LLC | 20,095,255 11.000% | 11,876,667 (+144.51%) | View |
| 2020-04-27 4:33 pm Purchase | 13G | Actinium Pharmaceuticals Inc. ATNM | BIGGER CAPITAL FUND L P | 20,955,778 5.400% | 12,310,391 (+142.39%) | View |
| 2020-02-14 4:15 pm Unchanged | 13G | Actinium Pharmaceuticals Inc. ATNM | BIGGER CAPITAL FUND L P | 8,645,387 4.900% | 0 (Unchanged) | View |
| 2020-01-07 6:41 pm Sale | 13G | Actinium Pharmaceuticals Inc. ATNM | SABBY MANAGEMENT LLC | 8,218,588 11.000% | -4,768,424 (-36.72%) | View |